45 Under 45 Leadership Excellence Platinum Awards 2026

45 Under 45 Leadership Excellence Platinum Awards 2026

HomeSri Lanka NewsSri Lankan Pharmaceutical Manufacturers Explore Export Opportunities at CPHI Worldwide 2026

Sri Lankan Pharmaceutical Manufacturers Explore Export Opportunities at CPHI Worldwide 2026

Published on

Sri Lankan pharmaceutical manufacturers explored export opportunities and international partnerships during an exposure visit to CPHI Worldwide 2026, held at Fiera Milano in Milan, Italy, from 6 to 8 October.

The Sri Lanka Export Development Board (EDB) facilitated the visit in collaboration with the Embassy of Sri Lanka in Rome and the Consulate General of Sri Lanka in Milan.

A delegation representing five companies participated: State Pharmaceutical Manufacturing Corporation, Siddhalepa Exports Ltd., Lina Manufacturing Ltd., Vetpharma Biotechnology Ltd. and Aithra Pharmaceuticals Ltd. Their businesses span pharmaceuticals, veterinary products, cosmeceuticals and natural products.

The programme combined exhibition visits with business networking sessions, enabling participants to meet potential buyers, distributors and industry partners while assessing opportunities in overseas markets.

CPHI connects businesses across the pharmaceutical value chain, including manufacturers, ingredient suppliers, contract development and manufacturing organisations, packaging providers and technical specialists.

Delegates explored developments in pharmaceutical production, emerging technologies, regulatory expectations and global supply chains. Discussions also addressed opportunities for product development, technical cooperation and market expansion.

The delegation engaged with international organisations including Barbados Pharmaceutical Inc., Orion GXP Consulting, Gruppo Farmalpresa, Intertek, Nanopharm and NATAC, alongside representatives of Tanzania’s Ministry of Health.

Access to regulated export markets requires manufacturers to meet applicable product registration, quality and manufacturing requirements. The visit aimed to improve participants’ understanding of these expectations and identify potential technology partnerships.

The initiative forms part of continuing efforts to strengthen international business linkages, promote Sri Lankan pharmaceutical products and improve the export sector’s competitiveness through cooperation with overseas missions.

LATEST NEWS

Jensen Huang Resigns as Nvidia CEO as AI Share Sell-Off Deepens

Nvidia co-founder Jensen Huang has resigned as Chief Executive Officer and President of the...

Sri Lanka’s 2027 Budget Charts a Path from Economic Stability to Transformation

Public investment would be maintained at more 4% of GDP Committee to assess suitability of...

Bank of Ceylon Records Rs. 94.1 Billion Pre-Tax Profit, Reinforcing Financial Strength and Investor Confidence

Bank of Ceylon (BOC) recorded a profit before tax of Rs. 94.1 billion for...

Gardiner Group Acquires The Pickle Island in Strategic Leisure Expansion

Gardiner Group has acquired The Pickle Island, a Sri Lankan pickleball venture focused on...

MORE LIKE THIS

Jensen Huang Resigns as Nvidia CEO as AI Share Sell-Off Deepens

Nvidia co-founder Jensen Huang has resigned as Chief Executive Officer and President of the...

Sri Lanka’s 2027 Budget Charts a Path from Economic Stability to Transformation

Public investment would be maintained at more 4% of GDP Committee to assess suitability of...

Bank of Ceylon Records Rs. 94.1 Billion Pre-Tax Profit, Reinforcing Financial Strength and Investor Confidence

Bank of Ceylon (BOC) recorded a profit before tax of Rs. 94.1 billion for...